دورية أكاديمية
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
| العنوان: | Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma |
|---|---|
| المؤلفون: | Matulonis, Ursula, Vergote, Ignace, Backes, Floor, Martin, Lainie P, McMeekin, Scott, Birrer, Michael, Campana, Frank, Xu, Yi, Egile, Coumaran, Ghamande, Sharad |
| بيانات النشر: | Academic Press |
| سنة النشر: | 2015 |
| المجموعة: | KU Leuven: Lirias |
| الوصف: | Patients with endometrial carcinoma who progress after first-line chemotherapy have a poor prognosis. Phosphoinositide 3-kinase (PI3K) inhibitors are investigational treatment options in this setting. This study evaluated the efficacy and safety of the PI3K inhibitor pilaralisib (SAR245408; XL147) in advanced or recurrent endometrial carcinoma. ; status: published |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 0090-8258 1095-6859 |
| العلاقة: | Gynecologic Oncology vol:136 issue:2 pages:246-53; https://lirias.kuleuven.be/handle/123456789/474937Test |
| DOI: | 10.1016/j.ygyno.2014.12.019 |
| الإتاحة: | https://doi.org/10.1016/j.ygyno.2014.12.019Test https://lirias.kuleuven.be/handle/123456789/474937Test |
| رقم الانضمام: | edsbas.D72431A8 |
| قاعدة البيانات: | BASE |
| تدمد: | 00908258 10956859 |
|---|---|
| DOI: | 10.1016/j.ygyno.2014.12.019 |